Status:
RECRUITING
Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Pregnant Women
Eligibility:
FEMALE
18+ years
Brief Summary
Demonstrate the efficacy of an ultra-early, non-invasive prenatal diagnostic method adaptable to various genetic indications to detect fetal chromosomal abnormalities.
Detailed Description
During pregnancy, biological screening for genetic diseases of the fetus cannot be implemented before the 11th week of amenorrhea whatever the technique used. This delay is long and distressing, parti...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Pregnant woman
- Singleton pregnancy
- Pregnancy between 7 and 16 weeks of amenorrhea (WA)
- Woman ≥ 18 years
- Woman who has signed an informed consent
- Woman affiliated to social security or equivalent scheme
- Exclusions Criteria:
- Person under guardianship or curatorship
- Person placed under legal protection
- Person unable to provide the participant with informed consent.
Exclusion
Key Trial Info
Start Date :
November 19 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06523543
Start Date
November 19 2024
End Date
September 1 2027
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Montpellier
Montpellier, France, 34295